ClinicalTrials.gg
Active, not recruitingNCT05574140B-GLADUpdated Nov 4, 2026

BreathinG-induced Myocardial and Cerebral Perfusion in Anxiety Disorders

An observational study in Generalized Anxiety Disorder and Oxygenation Sensitive CMR, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. Active, not recruiting at 1 site in Canada. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre · Observational

How we know

Updated Nov 4, 2026Now Active, not recruitingPrimary completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
84
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 50 studies in Generalized Anxiety Disorder with a site in Canada — 7 open to participants now, 11 under way, none of them phase 3. Generalized Anxiety Disorder · Canada.

Started
2022
with 4 others
Observational
5 of 50
1 open now
Primary completion
2027-05
later than 9 of 10 live
Registered
44th of 50
by date

Among the 50 studies in Generalized Anxiety Disorder with a site in Canada, this one is one of 5 that started in 2022, is one of 5 observational ones, reaches primary completion later than 9 of the 10 other live ones, and was the 44th registered.

Generalized Anxiety Disorder

518 studies on the registry are indexed under Generalized Anxiety Disorder; 125 are open to participants now.

Browse Generalized Anxiety Disorder studies →

Open to participants now

7 of the 50 studies in Generalized Anxiety Disorder with a site in Canada are open now. Recruiting first, the newest first:

2 more — sign in →

All 7 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 88 Generalized Anxiety Disorder studies recruiting now, 32 (36%) set no upper age limit and 54 (61%) stop at 75 or younger; 15 take children under 18; 16 take healthy volunteers.

This study: 18 Years to 55 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies in Generalized Anxiety Disorder with a site in Canada, or all of them as a file.
02

Study summary

This study aims to view variations in MRI measurements of the heart and the brain in people with anxiety versus healthy volunteers. The MRI measurements used will be Oxygenation-Sensitive Cardiac MRI (OS-CMR), a recent type of MRI which is safe, fast, and non-invasive.

Read the detailed description

The investigators will prospectively analyze OS-CMR data from patients with a generalized anxiety disorder from one site. The investigators will observe how an anxiety disorder affects the OS-CMR data. In a follow-up MRI scan, the investigators will look at the OS-CMR of a subgroup who have anxiety disorder and are also undertaking cognitive behavioural therapy to asses how and if this therapy affects the OS-CMR data.

03

Conditions studied

  • Generalized Anxiety Disorder
  • Oxygenation Sensitive CMR
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study will recruit patient participants who are identified as having Generalized Anxiety Disorder (GAD), as well as age-similar healthy volunteer participants.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patient population:

Age 18-55,

  • Confirmation of an anxiety disorder as identified by the PSWQ,
  • No known, current or history, of significant medical conditions that may affect or directly involve the neurological, cardiovascular or respiratory system (except anxiety and depression)
  • Non-smoker

Healthy Volunteers:

  • Age 18-55
  • No known, current or history, of significant medical conditions that may affect or directly involve the neurological, cardiovascular or respiratory system
  • Non-smoker

Exclusion criteria

Exclusion Criteria:

  • General MRI : pacemakers, defibrillating wires, implanted defibrillators, intracranial aneurysm clips, metallic foreign bodies in the eyes, pregnancy
  • History of significant neurological disease or illness that is not anxiety (e.g. Dementia, stroke)
  • Hemodynamically unstable conditions
  • Significant or uncontrolled arrhythmias
  • Severe pulmonary disease
  • Recent (\<90 days) myocardial infarction
  • Recent (\<90 days) surgery or coronary intervention
  • Consumption of caffeine (caffeinated beverages, coffee, tea, cocoa, chocolate) within 12h of the exam
  • Use of benzodiazepines or other short-acting anxiety medications (\<1 day)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
84 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patient Population

    Participants diagnosed with Generalized Anxiety Disorder

    Diagnostic Test: Cardiac MRI

  • Healthy Volunteers

    Participants with no pre-existing conditions and who are on no medications.

    Diagnostic Test: Cardiac MRI

Interventions

  • Diagnostic testCardiac MRI

    The 4-minute breathing maneuver comprised of 2 minutes of normal breathing and 1-min hyperventilation (rate of 30 breaths per minute) followed by a maximal breath-hold. This technique is used in Oxygenation Sensitive CMR, a type of MRI, and will induce a vasoactive response visible in cardiac and cerebral MRI images

    Also known as: Breathing Maneuvers

06

What researchers measure

Primary outcomes

  1. Change in Signal Intensity

    Change in signal intensity between the baseline signal intensity and the signal intensity at 30 seconds of breath hold

    Time frame: Baseline

07

Study locations

1 site
  • Emotional Health CBT Clinic
    Montreal, Quebec H4A 3L5, Canada
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2022 (actual). Primary completion is estimated for May 2027, 57 months after the start.

Of 24 observational studies under Generalized Anxiety Disorder, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 56. This study's planned 57 months is above that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: primary completion Mar 2025 → May 2027 and completion Sep 2025 → Jul 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2022
First posted
Oct 10, 2022
StartActual
Jul 15, 2022
Primary completionEst.
May 1, 2027was Mar 2025
CompletionEst.
Jul 1, 2027was Sep 2025
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Nov 4, 2026
Sites
1 site added, 1 site removed
Show site
  • Emotional Health CBT Clinic · Montreal, Canada
Show 1 removed
  • Emotional Health CBT Clinic · Montréal, Canada
Nov 4, 2026
Primary completion
Mar 15, 2025→May 1, 2027
Nov 4, 2026
Study completion
Sep 15, 2025→Jul 1, 2027
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Recruiting→Active, not recruiting
    1 site added, 1 site removed
    Show site
    • Emotional Health CBT Clinic · Montreal, Canada
    Show 1 removed
    • Emotional Health CBT Clinic · Montréal, Canada
    Primary completion Mar 15, 2025→May 1, 2027
    Study completion Sep 15, 2025→Jul 1, 2027
    + 4 other changes: verification date, oversight details, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05574140
Responsible party
Matthias Friedrich (Principal Investigator, McGill University Health Centre/Research Institute of the McGill University Health Centre) — Principal investigator
First posted
Oct 10, 2022
Start date
Jul 15, 2022
Primary completion
May 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Nov 4, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion